Offer - Urjas Oil for just ₹ 1 X
Olmizide-H is an allopathic medicine The correct dosage of Olmizide-H depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Olmizide-H is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Olmizide-H safe for pregnant women?
Olmizide-H is safe to take during pregnancy.
Is the use of Olmizide-H safe during breastfeeding?
Breastfeeding women can safely use Olmizide-H.
What is the effect of Olmizide-H on the Kidneys?
Olmizide-H may have mild side effects on the kidneys.
What is the effect of Olmizide-H on the Liver?
Side effects of Olmizide-H rarely affect the liver.
What is the effect of Olmizide-H on the Heart?
Olmizide-H may have mild side effects on the heart. Most people will never see any effect on the heart.
Olmizide-H should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmizide-H unless your doctor advises you to do so -
Is this Olmizide-H habit forming or addictive?
Olmizide-H does not cause addiction.
Interaction between Food and Olmizide-H
Some foods when eaten with Olmizide-H can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olmizide-H
Consult your doctor before consuming alcohol while taking Olmizide-H as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448